Table 5.
Tested factor | Blood cell counts | Markers of inflammation | MASP-2 | ||||
---|---|---|---|---|---|---|---|
WBC | ANC | PLT | CRP | FBG | PCT | ||
(A) | |||||||
Ficolin-1 | r = 0.58 | r = 0.52 | r = 0.41 | r = −0.09 | r = −0.52 | r = 0.49 | r = −0.08 |
p < 0.000001 | p < 0.000001 | p < 0.000001 | p = 0.67 | p = 0.0001 | p = 0.03 | p = 0.02 | |
n = 791 | n = 783 | n = 789 | n = 517 | n = 49 | n = 20 | n = 842 | |
Ficolin-2 | r = 0.16 | r = 0.14 | r = 0.28 | r = −0.2 | r = −0.26 | r = −0.56 | r = −0.09 |
p = 0.00001 | p = 0.00007 | p < 0.000001 | p = 0.000004 | p = 0.069 | p = 0.01 | p = 0.012 | |
n = 783 | n = 775 | n = 781 | n = 511 | n = 49 | n = 20 | n = 835 | |
Ficolin-3 | r = 0.17 | r = 0.13 | r = 0.21 | r = −0.14 | r = −0.28 | r = 0.04 | r = 0.35 |
p = 0.000001 | p = 0.0004 | p < 0.000001 | p = 0.002 | p = 0.055 | p = 0.87 | p < 0.000001 | |
n = 791 | n = 783 | n = 789 | n = 517 | n = 49 | n = 20 | n = 843 | |
(B) | |||||||
Ficolin-1 | r = 0.69 | r = 0.56 | r = 0.36 | r = −0.22 | r = −0.26 | r = 0.19 | r = −0.18 |
p < 0.000001 | p < 0.000001 | p < 0.000001 | p = 0.0001 | p = 0.027 | p = 0.2 | p = 0.00003 | |
n = 463 | n = 443 | n = 462 | n = 302 | n = 72 | n = 48 | n = 542 | |
Ficolin-2 | r = 0.07 | r = −0.02 | r = 0.18 | r = −0.08 | r = −0.18 | r = −0.06 | r = 0.03 |
p = 0.11 | p = 0.72 | p = 0.00008 | p = 0.14 | p = 0.14 | p = 0.68 | p = 0.45 | |
n = 462 | n = 442 | n = 462 | n = 301 | n = 72 | n = 48 | n = 541 | |
Ficolin-3 | r = 0.18 | r = 0.14 | r = 0.14 | r = −0.13 | r = −0.3 | r = 0.49 | r = 0.18 |
p = 0.00009 | p = 0.003 | p = 0.003 | p = 0.02 | p = 0.01 | p = 0.0004 | p = 0.00002 | |
n = 463 | n = 443 | n = 462 | n = 302 | n = 72 | n = 48 | n = 542 |
(A) patients suffering from multiple myeloma; (B) patients suffering from lymphomas.
WBC, white blood cell count; ANC, absolute neutrophil count; PLT, platelet count; CRP, C-reactive protein; FBG, fibrinogen; PCT, procalcitonin.